Misplaced Pages

Bibrocathol: Difference between revisions

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 14:52, 11 April 2023 editEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers174,394 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper← Previous edit Revision as of 15:26, 23 September 2023 edit undoOzzie10aaaa (talk | contribs)Autopatrolled, Extended confirmed users, New page reviewers214,308 editsm Cleaned up using AutoEdNext edit →
Line 7: Line 7:


<!--Clinical data--> <!--Clinical data-->
| tradename = | tradename =
| Drugs.com = {{drugs.com|international|bibrocathol}} | Drugs.com = {{drugs.com|international|bibrocathol}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X --> | pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = | pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> | legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> | legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = | legal_status =
| routes_of_administration = Topical (eye ointment) | routes_of_administration = Topical (eye ointment)


<!--Pharmacokinetic data--> <!--Pharmacokinetic data-->
| bioavailability = | bioavailability =
| protein_bound = | protein_bound =
| metabolism = | metabolism =
| elimination_half-life = | elimination_half-life =
| excretion = | excretion =


<!--Identifiers--> <!--Identifiers-->
Line 37: Line 37:
| PubChem = 16683103 | PubChem = 16683103
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = | DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 11232581 | ChemSpiderID = 11232581
Line 46: Line 46:


<!--Chemical data--> <!--Chemical data-->
| chemical_formula = | chemical_formula =
| C=6 | H=1 | Bi=1 | Br=4 | O=3 | C=6 | H=1 | Bi=1 | Br=4 | O=3
| smiles = O1Oc2c(Br)c(Br)c(Br)c(Br)c2O1 | smiles = O1Oc2c(Br)c(Br)c(Br)c(Br)c2O1
| synonyms = Bibrocathin<br>Tetrabromopyrocatechol&nbsp;bismuth | synonyms = Bibrocathin<br>Tetrabromopyrocatechol&nbsp;bismuth
Line 57: Line 57:


==External links== ==External links==
*{{Commonscatinline}} * {{Commonscatinline}}


{{Bismuth compounds}} {{Bismuth compounds}}

Revision as of 15:26, 23 September 2023

Chemical compound Pharmaceutical compound
Bibrocathol
Clinical data
Other namesBibrocathin
Tetrabromopyrocatechol bismuth
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Topical (eye ointment)
ATC code
Identifiers
IUPAC name
  • 4,5,6,7-tetrabromo-2-hydroxy-1,3,2-benzodioxabismole
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.027.294 Edit this at Wikidata
Chemical and physical data
FormulaC6HBiBr4O3
Molar mass649.667 g·mol
3D model (JSmol)
SMILES
  • O1Oc2c(Br)c(Br)c(Br)c(Br)c2O1
InChI
  • InChI=1S/C6H2Br4O2.Bi.H2O/c7-1-2(8)4(10)6(12)5(11)3(1)9;;/h11-12H;;1H2/q;+3;/p-3
  • Key:VTAVFIZOZUAKKE-UHFFFAOYSA-K
  (what is this?)  (verify)

Bibrocathol (INN, trade names Noviform and Posiformin) is the substance 4,5,6,7-Tetrabrom-1,3,2-benzodioxabismol-2-ol. It contains bismuth and is used to treat eye infections and control swelling.

References

  1. Gurtler L (January 2002). "Chapter 2: The Eye and Conjunctiva as Target of Entry for Infectious Agents: Prevention by Protection and by Antiseptic Prophylaxis". In Kramer A, Behrens-Baumann W (eds.). Antiseptic prophylaxis and therapy in ocular infections: principles, clinical practice, and infection control. Developments in Ophthalmology. Vol. 33. Basel: Karger. pp. 9–13. doi:10.1159/000065934. ISBN 978-3-8055-7316-0. PMID 12236131.

External links

Bismuth compounds
Bismuth(III)
Organobismuth(III)
Bismuth(V)
Organobismuth(V)


Stub icon

This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it.

Categories:
Bibrocathol: Difference between revisions Add topic